|
Discovery, Biology and Risk of Inherited Variants in Glioma
|
1R01CA217105-01A1
|
$1,043,807
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ9) Directed and unbiased studies of synaptic injuries as sequelae of radiotherapy: mapping, sex-dependence, and reversal
|
5R01CA219667-02
|
$523,048
|
DUMAN, JOSEPH
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Sox9/NFIA Transcriptional Network In Malignant Glioma
|
5K01CA190235-04
|
$140,400
|
GLASGOW, STACEY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cognitive Change after Proton RT vs. Photon or Surgery for Pediatric Brain Tumor
|
5R01CA187202-05
|
$577,030
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Context-Specific Functional Annotation of EGFR Mutations in Glioblastoma
|
5F32CA221015-02
|
$59,038
|
KONG, KATHLEEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
3R01CA215452-02S1
|
$7,156
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and Targeting Onocgenic MYC Enhancer Control in Pediatric Tumors
|
3R01CA215452-02S2
|
$45,800
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
5R01CA215452-02
|
$362,569
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
MOLECULAR DISSECTION OF SEIZURE MICROENVIRONMENT IN MALIGNANT GLIOMA
|
1R01CA223388-01
|
$632,130
|
NOEBELS, JEFFREY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
|
5R01CA155769-07
|
$410,877
|
BADIE, BEHNAM
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cell-Selective CpG-STAT3 Inhibitors for Radioimmunotherapy of Malignant Glioma
|
1R01CA215183-01A1
|
$529,603
|
KORTYLEWSKI, MARCIN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas
|
5R01CA198076-04
|
$546,873
|
PORTNOW, JANA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Development and validation of a computational prediction model for exogenous neural stem cell migration to sites of brain tumors
|
1R03CA216142-01A1
|
$86,500
|
ROCKNE, RUSSELL
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
2P30CA033572-35
|
$2,543,187
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-35S1
|
$43,750
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Refinement of CAR-T-Cell therapy targeting glioblastomas
|
1F99CA234923-01
|
$30,024
|
WANG, DONGRUI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
|
1R01CA229784-01
|
$667,694
|
CHAREST, ALAIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases.
|
1R44CA228694-01
|
$300,000
|
SILBERSTEIN, DAVID
|
BIOMIMETIX JV, LLC
|
|
Epigenetic regulation of cellular plasticity and cancer cell fate
|
5R35CA210104-02
|
$1,062,000
|
SHI, YANG
|
BOSTON CHILDREN'S HOSPITAL
|
|
Co-targeting mTOR and YAP signaling in glioblastoma
|
1R01CA217820-01A1
|
$320,490
|
GERA, JOSEPH
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S1
|
$3,249,644
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S2
|
$1,000,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
|
2P01CA163205-06A1
|
$1,889,731
|
CHIOCCA, E
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model
|
5R01CA195532-04
|
$377,464
|
CHIOCCA, E
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
MicroRNA128 Regulation of Polycomb Repressor Complexes1 and 2 in Glioblastoma
|
5R01CA176203-05
|
$346,546
|
GODLEWSKI, JAKUB
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Developing miR-10b targeting for glioblastoma
|
1R01CA215072-01A1
|
$408,884
|
KRICHEVSKY, ANNA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
In vivo imaging of the stem cell loaded oncolytic viruses for cancer therapy
|
5R01CA204720-03
|
$386,339
|
SHAH, KHALID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas
|
5R01CA219943-02
|
$507,552
|
BEROUKHIM, RAMEEN
|
BROAD INSTITUTE, INC.
|
|
Center of Excellence for High Throughput Proteogenomic Characterization
|
5U24CA210986-03
|
$1,288,045
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
|
DECONVOLUTION OF CLONAL HETEROGENEITY FROM BULK AND SINGLE-CELL VARIATION DATA
|
5R21CA216452-02
|
$154,940
|
SCHWARTZ, RUSSELL
|
CARNEGIE-MELLON UNIVERSITY
|
|
Targeting Brain Tumor Stem Cells In The Hypoxic Microenvironment
|
5R01CA187780-04
|
$362,569
|
BAR, ELI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
|
5R01CA217956-02
|
$688,403
|
BRADY-KALNAY, SUSANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Treatment of glioblastoma using targeted nanoparticles
|
3U01CA198892-04S1
|
$66,200
|
COVARRUBIAS, GIL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-28
|
$5,637,954
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-28S1
|
$249,965
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Contribution of Gynecologic and Breast Cancer Biospecimens from African American women to HCMI
|
3P30CA043703-28S2
|
$48,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Epigenetic Regulation of Lipid Metabolism in Glioma Stem Cells
|
5F30CA217065-03
|
$44,524
|
GIMPLE, RYAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Treatment of glioblastoma using chain-like nanoparticles
|
5U01CA198892-04
|
$561,808
|
KARATHANASIS, EFSTATHIOS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeting TCA cycle in Brain Tumor Initiating Cells
|
5F30CA203101-04
|
$44,524
|
KIM, JIN YOUNG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-05
|
$1,187,291
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Mitochondrial Dynamics in Brain TumorInitiating Cells
|
5R01CA208516-02
|
$320,000
|
MEARS, JASON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
The Unfolded Protein Response in Glioblastoma
|
5F30CA217066-03
|
$47,683
|
PRAGER, BRIANA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers
|
5R33CA202900-03
|
$418,127
|
BREUNIG, JOSHUA
|
CEDARS-SINAI MEDICAL CENTER
|
|
Glial tumor image-guided surgery and treatment
|
5R01CA209921-03
|
$519,467
|
HOLLER, EGGEHARD
|
CEDARS-SINAI MEDICAL CENTER
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|